Richard O. Iii Cannon

Richard O. Iii Cannon's AcademicInfluence.com Rankings

Philosophy

#6088

World Rank

#9060

Historical Rank

Logic

#3282

World Rank

#4413

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Richard O. Iii Cannon's Degrees

Doctorate Medicine Stanford University

Why Is Richard O. Iii Cannon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard O. Iii Cannon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. (2003) (5024)
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation (2003) (1681)
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease (2002) (684)
"Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. (1988) (596)
Acute Vascular Effects of Estrogen in Postmenopausal Women (1994) (580)
Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women (1994) (571)
The emerging biology of the nitrite anion (2005) (557)
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. (2002) (539)
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. (1994) (512)
Imipramine in patients with chest pain despite normal coronary angiograms. (1994) (490)
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. (1995) (475)
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. (1985) (463)
Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. (1988) (448)
Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. (2000) (445)
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. (1995) (440)
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). (1987) (410)
Cardiac Sympathetic Denervation in Parkinson Disease (2000) (352)
Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. (2002) (348)
Pathophysiological dilemma of syndrome X. (1992) (342)
Role of nitric oxide in cardiovascular disease: focus on the endothelium. (1998) (340)
Angina caused by reduced vasodilator reserve of the small coronary arteries. (1983) (339)
Nitrite Infusion in Humans and Nonhuman Primates: Endocrine Effects, Pharmacokinetics, and Tolerance Formation (2007) (338)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. (2004) (333)
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. (1989) (332)
Impact of Dual‐Chamber Permanent Pacing in Patients With Obstructive Hypertrophic Cardiomyopathy With Symptoms Refractory to Verapamil and β‐Adrenergic Blocker Therapy (1992) (307)
Sympathetic cardioneuropathy in dysautonomias. (1997) (306)
Role of endothelin in the increased vascular tone of patients with essential hypertension. (1999) (287)
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. (2001) (276)
Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? (1987) (273)
Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. (1985) (270)
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. (1997) (263)
The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. (2009) (262)
Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. (1999) (260)
Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease (2004) (255)
Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease (2003) (254)
Endothelial Dysfunction in Patients With Chest Pain and Normal Coronary Arteries (1992) (253)
The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. (1997) (253)
Phenotype and course of Hutchinson-Gilford progeria syndrome. (2008) (252)
Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women (1997) (239)
Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. (1990) (231)
Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. (2005) (231)
Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. (1995) (220)
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity (2006) (206)
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. (1989) (195)
Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. (1996) (187)
Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. (1994) (186)
Myocardial Metabolic, Hemodynamic, and Electrocardiographic Significance of Reversible Thallium‐201 Abnormalities in Hypertrophic Cardiomyopathy (1991) (181)
Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. (2000) (178)
Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction (2008) (176)
Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. (1987) (173)
Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. (1997) (172)
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. (2006) (170)
Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. (1985) (169)
Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. (2000) (166)
Selective Loss of Microvascular Endothelial Function in Human Hypercholesterolemia (1994) (166)
Oral L-arginine in patients with coronary artery disease on medical management. (2000) (164)
Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. (2000) (162)
Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. (1997) (158)
Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. (1986) (155)
Minimum left ventricular pressure during beta-adrenergic stimulation in human subjects. Evidence for elastic recoil and diastolic "suction" in the normal heart. (1990) (155)
Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. (1995) (154)
Nitric oxide activity in the atherosclerotic human coronary circulation. (1997) (153)
Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. (1997) (148)
Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. (1998) (148)
Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. (1987) (146)
Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. (2009) (143)
Cardiovascular complications in renal failure. (1991) (138)
Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. (1995) (136)
Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe. (1983) (132)
Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine (1992) (131)
Initial Results of Combined Anterior Mitral Leaflet Plication and Ventricular Septal Myotomy‐Myectomy for Relief of Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy (1992) (130)
Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation. (1998) (130)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. (2004) (119)
Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. (1987) (116)
Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. (1999) (112)
Chest pain and "normal" coronary arteries--role of small coronary arteries. (1985) (112)
Vascular effects of estrogen and vitamin E therapies in postmenopausal women. (1999) (109)
Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction (2005) (109)
Iron metabolism in human pregnancy as studied with radioactive isotope, Fe59. (1951) (106)
Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteries. (1990) (106)
Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women. (1997) (106)
Cardiac Sympathetic Dysautonomia in Chronic Orthostatic Intolerance Syndromes (2002) (101)
Hemodynamic principles in the control of coronary blood flow. (1985) (101)
Effect of combined 17 beta-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women. (1995) (99)
Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. (1989) (98)
Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. (1997) (96)
Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. (1989) (93)
Increased activity of endogenous endothelin in patients with hypercholesterolemia. (2000) (90)
Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. (1994) (89)
Early degradation of collagen after acute myocardial infarction in the rat. (1983) (89)
Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. (1997) (88)
Competition for p300 Regulates Transcription by Estrogen Receptors and Nuclear Factor-&kgr;B in Human Coronary Smooth Muscle Cells (2000) (87)
Noninvasive Determination of Spatially Resolved and Time-Resolved Tissue Perfusion in Humans During Nitric Oxide Inhibition and Inhalation by Use of a Visible-Reflectance Hyperspectral Imaging Technique (2001) (86)
Clinical evaluation of impedance cardiography. (1986) (84)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 2: stable ischemia: pathophysiology and gender differences. (2004) (83)
Effects of Physiological Levels of Estrogen on Coronary Vasomotor Function in Postmenopausal Women (1994) (83)
Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. (1995) (82)
Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. (1989) (81)
Statin Attenuates Increase in C-Reactive Protein During Estrogen Replacement Therapy in Postmenopausal Women (2002) (79)
Systemic Amyloidosis Presenting with Angina Pectoris (1999) (79)
Three year anatomic, functional and clinical follow-up after successful percutaneous transluminal coronary angioplasty. (1987) (77)
Mechanism by which quinapril improves vascular function in coronary artery disease. (1999) (77)
Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy. (1991) (75)
Systemic and left ventricular responses to exercise stress in asymptomatic patients with valvular aortic stenosis. (1991) (75)
Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. (1993) (75)
The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia. (1988) (74)
Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide. (2003) (73)
Effects of Hormone Replacement Therapy on Coagulation, Fibrinolysis, and Thrombosis Risk in Postmenopausal Women (1999) (72)
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). (1987) (71)
Clinical factors useful in predicting aortic valve structure in patients > 40 years of age with isolated valvular aortic stenosis. (1993) (70)
Role of nitric oxide in the vasodilator response to mental stress in normal subjects. (1997) (68)
Beta-adrenergic stimulation with isoproterenol enhances left ventricular diastolic performance in hypertrophic cardiomyopathy despite potentiation of myocardial ischemia. Comparison to rapid atrial pacing. (1989) (64)
Impact of Surgical Relief of Outflow Obstruction on Thallium Perfusion Abnormalities in Hypertrophic Cardiomyopathy (1992) (64)
Antioxidant Effect of Estrogen on Cytomegalovirus-Induced Gene Expression in Coronary Artery Smooth Muscle Cells (2000) (63)
Endothelial Progenitor Cell Mobilization and Increased Intravascular Nitric Oxide in Patients Undergoing Cardiac Rehabilitation (2007) (62)
Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. (1995) (61)
Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women. (2000) (61)
Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women. (1995) (60)
The Vanderbilt cooperative study of maternal and infant nutrition. IV. Dietary, laboratory and physical findings in 2,129 delivered pregnancies. (1953) (60)
Arterial wall MRI characteristics are associated with elevated serum markers of inflammation in humans (2001) (59)
Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction (2009) (57)
Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. (1998) (56)
Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy. (1993) (54)
Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy. (1985) (53)
Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients. (1998) (53)
The sensitive heart. A syndrome of abnormal cardiac pain perception. (1995) (52)
Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. (1991) (52)
Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. (1992) (51)
Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy. (1994) (50)
Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function. (1998) (50)
The Vanderbilt cooperative study of maternal and infant nutrition. VI. Relationship of obstetric performance to nutrition. (1954) (50)
Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. (1989) (48)
Platelet hyperaggregability across the coronary bed in response to rapid atrial pacing in patients with stable coronary artery disease. (1992) (46)
Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy. (1984) (45)
Microarray-Based Characterization of a Colony Assay Used to Investigate Endothelial Progenitor Cells and Relevance to Endothelial Function in Humans (2009) (43)
Airway hyperresponsiveness in patients with microvascular angina. Evidence for a diffuse disorder of smooth muscle responsiveness. (1990) (42)
Comparison of Exercise Testing With Studies of Coronary Flow Reserve in Patients With Microvascular Angina (1991) (42)
Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women. (1999) (42)
The Vanderbilt cooperative study of maternal and infant nutrition. V. Description and outcome of obstetric sample. (1953) (41)
AHA / CDC Scientific Statement Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice : A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association (2003) (41)
Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women. (2000) (41)
Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. (1991) (40)
Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. (1995) (37)
Exercise Testing in Patients With Microvascular Angina (1991) (37)
Platypnea and interatrial right-to-left shunting after lobectomy. (1983) (36)
Chest pain with normal coronary angiograms. (1993) (36)
Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research. (2005) (36)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials. (2004) (35)
Microvascular Angina and Panic Disorder (1990) (35)
Chest pain in women with normal coronary angiograms. (2000) (35)
Microvascular angina. Cardiovascular investigations regarding pathophysiology and management. (1991) (33)
Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo. (1983) (33)
Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects. (2006) (32)
Cardiovascular benefit of cholesterol-lowering therapy: does improved endothelial vasodilator function matter? (2000) (31)
Beneficial and detrimental effects of lidoflazine in microvascular angina. (1990) (31)
Indices of sympathetic vascular innervation in sympathectomized patients. (1986) (30)
Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris. (1995) (30)
Predictors of endothelial function in employees with sedentary occupations in a worksite exercise program. (2008) (29)
Aminophylline for angina: the "Robin Hood" effect? (1989) (29)
Endothelium, nitric oxide, and atherosclerosis (1999) (28)
Raloxifene-Mediated Increase in Matrix Metalloproteinase-1 Production by Activated Monocytes (2001) (27)
Does coronary endothelial dysfunction cause myocardial ischemia in the absence of obstructive coronary artery disease? (1997) (27)
Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women. (2000) (26)
Enhanced regional left ventricular function after distant coronary bypass by means of improved collateral blood flow. (1989) (26)
Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women. (2002) (26)
Assessing risk in hypertrophic cardiomyopathy. (2003) (25)
Comparison of coronary endothelial dynamics with electrocardiographic and left ventricular contractile responses to stress in the absence of coronary artery disease. (1998) (25)
A Clinical Service to Support the Return of Secondary Genomic Findings in Human Research. (2016) (25)
Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. (2008) (23)
Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy. (1992) (23)
Improved specificity of transesophageal dobutamine stress echocardiography compared to standard tests for evaluation of coronary artery disease in women presenting with chest pain. (1997) (23)
Left ventricular pulsus alternans in patients with hypertrophic cardiomyopathy and severe obstruction to left ventricular outflow. (1986) (23)
High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women. (2012) (23)
Causes of chest pain in patients with normal coronary angiograms: the eye of the beholder. (1988) (22)
A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus. (2007) (21)
Chest pain as a consequence of abnormal visceral nociception (1993) (21)
Dynamic coronary obstruction as a cause of angina pectoris: implications regarding therapy. (1985) (21)
Chronic deterioration in left ventricular function in patients with microvascular angina (1991) (20)
Comparative effects of verapamil and nitroprusside on left ventricular function in patients with hypertension. (1989) (20)
Selective Estrogen Receptor Modulator Effects on Serum Lipoproteins and Vascular Function in Postmenopausal Women and in Hypercholesterolemic Men (2001) (19)
Reoperation for persistent outflow obstruction in hypertrophic cardiomyopathy. (1991) (19)
Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease. (2012) (17)
Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator raloxifene in hypercholesterolemic men. (2000) (17)
Randomized trial of nutrition education added to internet-based information and exercise at the work place for weight loss in a racially diverse population of overweight women (2013) (17)
Restenosis after angioplasty. (2002) (16)
Role of cellular proteinases in acute myocardial infarction. II. Influence of in vivo suppression of myocardial proteolysis by antipain, leupeptin and pepstatin on myocardial infarct size in the rat. (1983) (16)
Effect of left ventricular septal myectomy on concurrent mitral regurgitation. (1989) (16)
Acquired left ventricular endocardial constriction from massive mural calcific deposits: a newly recognized cause of impairment to left ventricular filling. (1984) (15)
Angina pectoris with normal coronary angiograms. (1991) (15)
The Vanderbilt cooperative study of maternal and infant nutrition. VII. Tocopherol in relation to pregnancy. (1955) (15)
Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease. (2009) (13)
The heart in hypertension. Thinking small. (1996) (13)
Effect of ibuprofen on the healing phase of experimental myocardial infarction in the rat. (1985) (13)
Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophie cardiomyopathy (1988) (13)
Insulin and Extremity Muscle Mass in Overweight and Obese Women (2013) (13)
Platelet activation in stable coronary artery disease. (1994) (12)
Medical and surgical therapy of hypertrophic cardiomyopathy. (1988) (12)
Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy. (2009) (11)
Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: the role of nitric oxide. (1998) (11)
Transcriptional profiling of CD133(+) cells in coronary artery disease and effects of exercise on gene expression. (2011) (11)
Hepatocellular adenoma in a young woman with beta-thalassemia and secondary iron overload. (1981) (10)
NO solutions? (2002) (10)
Comparison of exercise radionuclide angiography with thallium SPECT imaging for detection of significant narrowing of the left circumflex coronary artery. (1991) (10)
Ischemia, Coronary Blood Flow, and Coronary Reserve in Hypertrophic Cardiomyopathy (1990) (10)
Ischemia at a distance—So close yet so far* (1985) (10)
Search for Predictors of Nontherapeutic INR Results with Warfarin Therapy (2005) (9)
Late (5 to 132 months) clinical and hemodynamic results after either tricuspid valve replacement or anuloplasty for Ebstein's anomaly of the tricuspid valve. (1984) (9)
Syndrome X. "What's in a name...?". (1989) (8)
THE BIOCHEMICAL ASSESSMENT OF NUTRITIONAL STATUS DURING PREGNANCY (1948) (8)
Chest pain with normal coronary angiograms: is the heart innocent or guilty? (1990) (8)
Bioprostheses in tricuspid and mitral valve positions for 100 months with heavier calcific deposits on the left-sided valve followed by new bioprostheses in both positions for 95 months with heavier calcific deposits on the right-sided valve. (1988) (8)
Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels. (2013) (8)
BM-derived cell therapies for cardiovascular disease. (2007) (8)
Atorvastatin Therapy Restores Nitric Oxide-Dependent Vascular Responsiveness in Patients with Sickle Cell Disease. (2004) (8)
Appearance of or persistence of severe mitral regurgitation without left ventricular outflow obstruction after partial ventricular septal myotomy-myectomy in hypertrophic cardiomyopathy. (1991) (7)
Oral L-arginine (and other active ingredients) for ischemic heart disease?. (2002) (7)
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxidedelivery (2021) (7)
Opinions and research priorities. (2005) (7)
A Randomized, Placebo‐Controlled, Crossover, Ascending Dose Tolerance and Pharmacokinetic Study of CVT‐3146: A Novel Agent For Potential Use in Myocardial Perfusion Imaging (2003) (6)
, in Patients With Coronary Artery Disease Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells (2005) (6)
Cardiovascular potential of BM-derived stem and progenitor cells. (2004) (5)
Successful treatment of invasive pulmonary aspergillosis in the immunocompromised host. (1978) (5)
Myocardial ischemia in hypertrophic cardiomyopathy. (1987) (5)
Circulating endothelial progenitor cells in adults with sickle cell disease (2013) (5)
Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: the role of nitric oxide (1998) (5)
The coronary microcirculation in heart disease: hypertrophic cardiomyopathy, hypertension, and microvascular angina (1992) (5)
Parameters of coagulant and fibrinolytic capacity and activity in postmenopausal women: within-subject variability. (2002) (4)
Hormone Replacement Therapy for Prevention or Treatment of Atherosclerosis in Postmenopausal Women: Promises, Controversies, and Clinical Trials (2000) (4)
Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophic cardiomyopathy. (1988) (4)
Myocardial ischemia due to dynamic small vessel coronary artery disease. (1985) (4)
CME Paper: Hormone Replacement Therapy for Prevention or Treatment of Atherosclerosis in Postmenopausal Women: Promises, Controversies, and Clinical Trials. (2000) (4)
Diagnosis of coronary artery disease by radionuclide angiography: effect of combining indices of left ventricular function. (1989) (3)
Weight Loss Programs May Have Beneficial or Adverse Effects on Fat Mass and Insulin Sensitivity in Overweight and Obese Black Women (2014) (3)
Can measures of coronary dynamics explain chest pain without coronary artery disease? (1998) (3)
Iron Deficiency in Gynecologic Patients (1959) (3)
Patients With Stable Coronary Artery Disease (2005) (3)
Bone marrow-derived cells for cardiac repair. (2009) (3)
Acetylcholine and coronary artery spasm: important insight or squeeze play? (1988) (3)
The cardiovascular syndrome X: how to recognize and how to manage (1999) (2)
Early and late proteolysis in acute myocardial infarction (1981) (2)
Chest pain and the sensitive heart. (1995) (2)
Chest pain and the sensitive heart : Non-cardiac chest pain (1995) (2)
l ‐Arginine for the prevention and treatment of coronary artery disease (2001) (2)
Angina pectoris with angiographically normal coronary arteries: a clinical, hemodynamic, and metabolic study. (1986) (1)
Erratum: Corrigendum: The emerging biology of the nitrite anion (2006) (1)
Fibrinolytic potentiation by estrogen therapy at conventional dosage in postmenopausal woman is independent of coagulation pathway activation (1998) (1)
Immune responses to HMG-CoA reductase inhibitors in patients with abnormal lipid level (1996) (1)
MY APPROACH to chest pain with normal coronary arteries. (2016) (1)
Hematopoietic Stem Cells for Myocardial Regeneration (2007) (1)
Abstract 1279: “Dysfunctional” High-density Lipoprotein Despite Normal Cholesterol Content in Sedentary Obese Women (2009) (1)
Platelet Hyperaggregabilit Across the Coronary Bed in Response to Rapid Atrial Pacing in Patients With Stable Coronary Artery Disease (1992) (1)
1045-193 Granulocyte-colony stimulating factor mobilizes and activates endothelial progenitor cells in patients with coronary artery disease (2004) (1)
Comprar Tissue and Cell Donation: An Essential Guide | Julio Panza | 9781405163224 | Wiley (2009) (1)
How to manage chest pain in patients with normal coronary angiograms. (1997) (1)
Significance of ischemic-appearing ST segment depression during exercise testing in syndrome X (1991) (1)
How do red blood cells dilate blood vessels?--Reply. (2004) (0)
Angiotensin converting enzyme inhibition improves coronary flow mediated vasodilation (1997) (0)
Response to Letter Regarding Article, “Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction” (2009) (0)
III Vasodilator Function Matter ? Cardiovascular Benefit of Cholesterol-Lowering Therapy : Does Improved Endothelial (2000) (0)
Ventricular suction measurements by pressure volume relations (1987) (0)
COMMENTARY Bone marrow-derived cells for cardiac repair (2009) (0)
Hypertension with marked left ventricular hypertrophy. (1986) (0)
Diagnosis of Coronary Artery Disease by Radionucide Angiography: Effect of Combining Indices of Left Ventricular Function (2006) (0)
915-80 Investigation of Nitric Oxide Release from Human Coronary Arteries with Substance P (1995) (0)
1989:515-REPORTS ON HYPERTENSION Comparative Effects of Verapamil and Nitroprusside on Left Ventricular Function in Patients With Hypertension (2016) (0)
Role of endothelium-derived nitric oxide in the vasodilator response to mental stress (1996) (0)
METHODS OF FINANCING THE UNIVERSITY HOSPITALS (1952) (0)
Abstract 4052: Women Differ from Men in the Contribution of Vascular Progenitor Cells to Endothelial Function and Cardiovascular Risk (2006) (0)
Abstract P377: Insulin, Muscle Mass and Exercise Performance in Overweight Women (2012) (0)
Directions: Report of the National Heart, Lung and Blood Institute Workshop: October 2 Women's Ischemic Syndrome Evaluation : Current Status and Future Research (2012) (0)
Coronary flow reserve in patients with chest pain, angiographically normal coronary arteries and normal left ventricle, dilated cardiomyopathy, and hypertrophic cardiomyopathy. (1989) (0)
930-107 Does the Abnormal Endothelial Response of the Human Coronary Vasculature in Atherosclerosis Extend Beyond the Muscarinic Receptor? (1995) (0)
The Vanderbilt cooperative study of maternal and infant nutrition. I. Background. II. Methods. III. Description of the sample and data. (1953) (0)
Pathophysiologic mechanisms responsible for the clinical spectrum of hypertrophic cardiomyopathy (1985) (0)
Addition of statin attenuates the increase in C-reactive protein during estrogen replacement therapy in postmenopausal women (2002) (0)
Abstract P132: Effectiveness of a Worksite Wellness Program on Dietary Intake, Adiposity, Exercise Performance, Insulin Sensitivity, and Lipids in Overweight Women (2012) (0)
A Syndrome of Abnormal Cardiac Pain Perception (2016) (0)
A Statement for Healthcare Professionals From the Markers of Inflammation and Cardiovascular Disease: Application to Clinical (2003) (0)
2.W16.2 Effects of estrogen on the endothelium in postmenopausal women: Implications for atherosclerosis (1997) (0)
ECG GATED PRESSURE VOLUME RELATIONSHIPS UTILIZING SCINTIGRAPHIC IMAGE DATA. (1987) (0)
Elfects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy (2005) (0)
Management Strategies for Chest Pain in Patients with Normal Coronary Angiograms (1999) (0)
995-19 The Impact of Mental Stress and α-Adrenergic Activation on the Microcirculation of Patients with Coronary Artery Disease (1995) (0)
Abstract P297: Reduced Fat Mass and Improved Insulin Sensitivity in Overweight Black Women after Completion of 6-month Worksite Weight Loss Program (2013) (0)
The Heart in Hypertension (1996) (0)
Evaluation of myocardial function by invasive methods. (1985) (0)
Abstract 3950: Bone Marrow Progenitor Cells Repair the Endothelium Overlying Sites of Damaged Smooth Muscle Cells in the Ascending Aorta in a Mouse Model of Progeria (2008) (0)
Beneficial effect of estrogen therapy on fibrinotysis is independent of changes in low-density lipoprotein levels (1998) (0)
764-3 Transesophageal Dobutamine Stress Echocardiography for the Evaluation of Patients with Chest Pain and Normal Coronary Arteries (1995) (0)
Management of patients with hypertrophic cardiomyopathy (1991) (0)
Platelet activation across the coronary bed in patients with coronary artery disease (1991) (0)
The Microcirculation in Cardiac Hypertrophy (1993) (0)
The Coronary Circulation in Hypertrophy and in Syndrome X (1993) (0)
The search for a better exercise test. A self-fulfilling prophecy? (1996) (0)
WITHDRAWN: NIH conference on dietary supplements, coagulation, and antithrombotic therapies Session V. Panel experts: Opinions and research priorities; supplements affecting antithrombotic therapies: A cardiologist's perspective. Dietary supplements and the management of atrial fibrillation. (2005) (0)
Sympathetic cardioneuropathy in dysautonomias. (1997) (0)
CARDIOMYOPATHY Elfects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy (0)
909-3 Transesophageal Dobutamine Stress Echocardiography for Detection of Coronary Artery Disease in Women Presenting with Chest Pain: Comparison with Other Standard Tests (1995) (0)
Reducing Cardiovascular Risk in Postmenopausal Women: Estrogen or Statins? (2002) (0)
Interaction between nitric oxide and endothelin in the regulation of vascular tone in the human forearm (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard O. Iii Cannon?

Richard O. Iii Cannon is affiliated with the following schools: